- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03677583
Duckweed Intake Study (DIS)
Tolerance of Regular Intake of Duckweed Based Food Products
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study aims to study the impact of frequent intake of 150-180 gram duckweed on gastrointestinal complaints and several other health related biomarkers.
Objective: The primary objective is to investigate gastro-intestinal complaints during 11 day duckweed consumption. Secondary objectives are to assess blood based parameters related to general health and urine based biomarkers for kidney function and to investigate consumer acceptance.
Study design: The study has a randomised parallel design. Two different treatments will be evaluated e.g. a 11-day intervention with duckweed based meals and a 11-day intervention with control/spinach meals. At the start and at the end of the intervention we will collect a blood sample and a urine samples. Questionnaires about gut complaints, stool consistency and frequency, wellbeing, health complaints or other adverse effects will be collected daily during intervention and up to two days after the intervention.
Study population: We aim to include 24 healthy volunteers aged 18-50 years. Intervention: A 11-day intervention in which subjects will receive a daily lunch with 150-180g wet weight duck weed or spinach. Products will be incorporated in food products such as pasta, curry, soup etc.
Main study parameters/endpoints: The main study parameter is frequency and severity of gastro-intestinal complaints. Secondary outcomes are intestinal health parameters derived from blood and urine samples taken before and after the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gelderland
-
Wageningen, Gelderland, Netherlands, 6708 WG
- Stichting Wageningen Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- Apparently healthy men and women
- Age between 18 and 50 years
- Body mass index (BMI) between 18.5 and 24.9 kg/m2
Exclusion criteria
- Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease)
- History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints
- History of liver dysfunction (cirrhosis, hepatitis) or liver surgery
- Kidney dysfunction (self-reported)
- Use of medication that may influence the study results, such as gastric acid inhibitors or laxatives
- Reported slimming, medically prescribed or vegan/vegetarian diet
- Current smokers
- Alcohol intake ≥4 glasses of alcoholic beverages per day
- Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported)
- Abuse of illicit drugs
- Food allergies for products that we use in the study
- Participation in another clinical trial at the same time
- Being an employee of the department Consumer Science & Health group of Wageningen Food & Biobased Research
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Duckweed
daily lunch with 150-180g wet weight duck weed
|
various meal products such as meal soup, quiche, mashed potato, curry and pasta sauce
|
ACTIVE_COMPARATOR: Spinach
daily lunch with 150-180g wet weight spinach
|
various meal products such as meal soup, quiche, mashed potato, curry and pasta sauce
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in gastro-intestinal complaints
Time Frame: Daily, during 11 days of duckweed intake and up to three days after intake. By questionnaires and Visual Analogue Scale (VAS) scores; from no complains (minimal) to serious complains (maximum)). Higher values represent a worse outcome
|
bloated feeling, belching, abdominal pain, flatulence, nausea, diarrhoea, constipation measured via Visual Analogue Scale (VAS)
|
Daily, during 11 days of duckweed intake and up to three days after intake. By questionnaires and Visual Analogue Scale (VAS) scores; from no complains (minimal) to serious complains (maximum)). Higher values represent a worse outcome
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change in blood hemoglobin
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood glucose
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood Fe (Iron)
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood leukocyte cell counts
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood ALAT
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood GGT
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood eGFR
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood creatinine
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood CRP
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood zonulin
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
under fasting conditions
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in urinary biomarkers of health
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
oxalic acid
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
change in blood pressure
Time Frame: before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
systolic and diastolic bloodpressure
|
before (D=0) and after (D=11) 11 days of duckweed or spinach intake
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
fiber, fruit and vegetable intake
Time Frame: before the intervention (D=0), this questionaire provides insights in energy and macronutrient consumption
|
via a food frequency questionaire
|
before the intervention (D=0), this questionaire provides insights in energy and macronutrient consumption
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NL66051.081.18
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Complication
-
University Hospital of FerraraCompletedIntestinal Anastomosis Complication | Complication of Gastrointestinal AnastomosisItaly
-
Wageningen University and ResearchThe Protein BreweryCompleted
-
Azienda Policlinico Umberto ICompletedGastrointestinal ComplicationItaly
-
Lindenwood UniversityCompletedExercise Performance | Gastrointestinal Complication | Aerobic EnduranceUnited States
-
SafehealCompletedGastrointestinal Anastomotic ComplicationFrance, Belgium
-
Entac Medical Inc.RecruitingGastrointestinal ComplicationUnited States
-
Assiut UniversityNot yet recruitingEsophageal Diseases | Esophagostomy Complication
-
Mayo ClinicCompletedGastrointestinal Bleeding | Complication of Internal DeviceUnited States
-
National Taiwan University HospitalUnknownEsophageal Cancer | Anesthesia | Complication, PostoperativeTaiwan
-
Asst Melegnano e MartesanaEnrolling by invitationMortality | Nephrotoxicity | Respiratory Complication | Neurological Complication | Surgical Complication | Metabolic Complication | Cardiovascular ComplicationItaly
Clinical Trials on Duckweed
-
Wageningen University and ResearchCompleted